Evaluate and communicate risk to stakeholders.
Duncan Low
Advertisement
Duncan Low is a scientific executive director in process development at Amgen Inc.
Articles by Duncan Low
Adequate characterization of materials protects product quality.
Advertisement
Latest Updated Articles
Managing Raw Materials in the QbD Paradigm, Part 2: Risk Assessment and CommunicationPublished: December 1st 2010 | Updated:
Managing Raw Materials in the QbD Paradigm, Part 1: Understanding RisksPublished: November 1st 2010 | Updated:
Advertisement
Advertisement
Trending on BioPharm International
1
Advances in Continuous Manufacturing, Drug Delivery Lead CPHI Pharma Awards 2025
2
Establishing Risk Assessments for AI in Bio-Manufacturing
3
Strategic Shifts for Speed, Resilience, and Long-Term Sustainability in Biomanufacturing
4
EU Biopharma Strategy: Scaling Up to Tackle Funding Gaps and Drive Innovation
5
